Roatan, an underappreciated Caribbean island, has emerged as a hotspot for the affluent pursuing experimental longevity treatments. The charter city of Prospera, spearheaded by Erick Brimen, offers virtually tax-free living and minimal restrictions on medical experimentation. Among the groundbreaking therapies available is the controversial follistatin gene therapy, priced at $25,000, which is being touted for its potential to enhance longevity by promoting cellular repair. Initial human trials suggest promising outcomes, despite the treatment’s unapproved status in the U.S., thus attracting biohackers and wealthy clientele looking for cutting-edge health solutions.
Roatan, rapidly becoming a hub for the ultra-wealthy, offers experimental gene therapies without regulatory scrutiny, drawing in those seeking enhanced longevity and well-being.
In the charter city of Prospera, innovative medical treatments like follistatin gene therapy are being provided, despite their controversial status and lack of FDA approval.
Collection
[
|
...
]